Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable
Year: 2018
Type: article
Source: European Heart Journal
Institutions: Karolinska University Hospital, Karolinska Institutet, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, MultiMedica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Novo Nordisk (Denmark), University of Padua, Baylor College of Medicine, Campbell University, Boehringer Ingelheim (Germany), University of Leeds, AstraZeneca (Sweden), Brigham and Women's Hospital, University of Liège, Centre Hospitalier Universitaire de Liège, Helmholtz Munich, University of Helsinki, King Abdulaziz University, Finnish Institute for Health and Welfare, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Défaillance Cardiovasculaire Aiguë et Chronique, Université de Lorraine
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, cardiovascular risk, cardiovascular disease, cardioprotection, glucose-lowering therapy, SGLT2 inhibitors, GLP-1 receptor agonists, cardiovascular outcome trials, cardiovascular safety, treatment gap, cardiovascular mortality, cardiovascular risk stratification, cardiovascular risk communication, cardiovascular risk education
Open Access status: closed
OpenAlex ID: W2904596955
